55 /100
HIGH RISK
Score updated May 30, 2026

GTBP — GT Biopharma, Inc. Dilution Risk Tracker

Track GTBP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GTBP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
47%
🔄 Reverse Split 65%
• 50-day avg $0.39 below $1 exchange minimum
• 11 months cash with weak price
📉 Score Deterioration 40%
• Score rose 36 points recently (worsening)
💰 Capital Raise 15%
• Under 12 months cash (11mo)
🔔 Track GTBP — Get forecast alerts →

💹 Market Data

Market Cap$17.25M
Shares Outstanding36.06M
Float33.53M
Cash$8.92M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 25.3% shares (2025Q4 vs prior)
39 institutional holders · 483.1K shares
#1 CITADEL ADVISORS LLC 80.8K shares
#2 Scientech Research LLC 54.7K shares
#3 SeaCrest Wealth Management, LLC 50.0K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.08M
Days to Cover1.0
% of Float6.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2022
S-1 SHELF Apr 30, 2026
EFFECT EFFECT Jan 30, 2026
424B3 ATM Jan 30, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track GTBP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GTBP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GTBP
📊 GTBP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GTBP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.